OrbiMed’s Tessera Defense and Homeland Security Inc. HLSQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,409
Closed -$993K 114
2025
Q1
$993K Hold
9,409
0.02% 101
2024
Q4
$1.31M Hold
9,409
0.03% 108
2024
Q3
$1.82M Buy
9,409
+2,160
+30% +$783K 0.03% 109
2024
Q2
$4.63M Buy
7,249
+4,871
+205% +$3.28M 0.09% 92
2024
Q1
$2.03M Hold
2,378
0.04% 104
2023
Q4
$1.26M Sell
2,378
-19
-0.8% -$12K 0.03% 102
2023
Q3
$1.6M Hold
2,397
0.03% 115
2023
Q2
$1.64M Buy
2,397
+733
+44% +$426K 0.03% 118
2023
Q1
$964K Buy
1,664
+183
+12% +$116K 0.02% 116
2022
Q4
$525K Hold
1,481
0.01% 114
2022
Q3
$957K Hold
1,481
0.02% 128
2022
Q2
$2.05M Hold
1,481
0.04% 131
2022
Q1
$5.43M Hold
1,481
0.09% 119
2021
Q4
$4.5M Hold
1,481
0.06% 137
2021
Q3
$8.61M Buy
1,481
+263
+22% +$2.04M 0.09% 134
2021
Q2
$12.6M Hold
1,218
0.13% 115
2021
Q1
$16.5M Hold
1,218
0.15% 106
2020
Q4
$14.8M Hold
1,218
0.13% 112
2020
Q3
$14.7M Hold
1,218
0.18% 99
2020
Q2
$12.8M Hold
1,218
0.18% 90
2020
Q1
$16.2M Hold
1,218
0.27% 75
2019
Q4
$22.4M Buy
+1,218
New +$21M 0.32% 62

Other funds holding HLSQ

OrbiMed's HLSQ Position: Q2 2025 in Review

OrbiMed sold out of Tessera Defense and Homeland Security Inc. (HLSQ) in Q2 2025, closing a stake of 9,409 shares — an estimated $993K sold.

OrbiMed first reported a position in HLSQ in Q4 2019 and held it in 22 quarters. The position peaked at $22.4M in Q4 2019. 18 funds tracked by Wall St. Rank hold HLSQ as of Q2 2025.

  • OrbiMed reported no remaining Tessera Defense and Homeland Security Inc. position as of Q2 2025 after selling out during the quarter.
  • OrbiMed sold 9,409 Tessera Defense and Homeland Security Inc. shares in Q2 2025, an estimated $993K.
  • OrbiMed first reported a position in Tessera Defense and Homeland Security Inc. in Q4 2019 and held it in 22 quarters.
  • OrbiMed's Tessera Defense and Homeland Security Inc. position peaked at $22.4M in Q4 2019.
  • 18 funds tracked by Wall St. Rank held Tessera Defense and Homeland Security Inc. as of Q2 2025.

Based on OrbiMed's 13F filing for Q2 2025, filed 14 Aug 2025.